Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03030002 TxB2 cPLA2i 1.0 BCD110605C28 4.98 pmol/ml medium
LMFA03030002 TxB2 cPLA2i 1.0 BCD110605C30 5.42 pmol/ml medium
LMFA03030002 TxB2 cPLA2i 1.0 BCD110605C29 5.39 pmol/ml medium
LMFA03030002 TxB2 cPLA2i 20.0 BCD110605C64 5.35 pmol/ml medium
LMFA03030002 TxB2 cPLA2i 20.0 BCD110605C66 5.54 pmol/ml medium
LMFA03030002 TxB2 cPLA2i 20.0 BCD110605C65 5.26 pmol/ml medium
LMFA03030002 TxB2 PLDi 1.0 BCD110605C16 5.37 pmol/ml medium
LMFA03030002 TxB2 PLDi 1.0 BCD110605C17 5.45 pmol/ml medium
LMFA03030002 TxB2 PLDi 1.0 BCD110605C18 5.23 pmol/ml medium
LMFA03030002 TxB2 PLDi 20.0 BCD110605C54 5.37 pmol/ml medium
LMFA03030002 TxB2 PLDi 20.0 BCD110605C52 5.62 pmol/ml medium
LMFA03030002 TxB2 PLDi 20.0 BCD110605C53 5.67 pmol/ml medium
LMFA03030002 TxB2 KDO+cPLA2i 1.0 BCD110605C32 5.45 pmol/ml medium
LMFA03030002 TxB2 KDO+cPLA2i 1.0 BCD110605C31 5.27 pmol/ml medium
LMFA03030002 TxB2 KDO+cPLA2i 1.0 BCD110605C33 5.55 pmol/ml medium
LMFA03030002 TxB2 KDO+cPLA2i 20.0 BCD110605C68 5.37 pmol/ml medium
LMFA03030002 TxB2 KDO+cPLA2i 20.0 BCD110605C69 5.6 pmol/ml medium
LMFA03030002 TxB2 KDO+cPLA2i 20.0 BCD110605C67 5.64 pmol/ml medium
LMFA03030002 TxB2 KDO+PLDi 1.0 BCD110605C19 5.16 pmol/ml medium
LMFA03030002 TxB2 KDO+PLDi 1.0 BCD110605C20 5.41 pmol/ml medium
LMFA03030002 TxB2 KDO+PLDi 1.0 BCD110605C21 5.5 pmol/ml medium
LMFA03030002 TxB2 KDO+PLDi 20.0 BCD110605C56 6.04 pmol/ml medium
LMFA03030002 TxB2 KDO+PLDi 20.0 BCD110605C57 5.78 pmol/ml medium
LMFA03030002 TxB2 KDO+PLDi 20.0 BCD110605C55 5.68 pmol/ml medium
LMFA03030002 TxB2 KDO+ATP+cPLA2i 1.0 BCD110605C37 5.61 pmol/ml medium
LMFA03030002 TxB2 KDO+ATP+cPLA2i 1.0 BCD110605C38 5.76 pmol/ml medium
LMFA03030002 TxB2 KDO+ATP+cPLA2i 1.0 BCD110605C39 5.37 pmol/ml medium
LMFA03030002 TxB2 KDO+ATP+cPLA2i 20.0 BCD110605C74 5.99 pmol/ml medium
LMFA03030002 TxB2 KDO+ATP+cPLA2i 20.0 BCD110605C75 5.76 pmol/ml medium
LMFA03030002 TxB2 KDO+ATP+cPLA2i 20.0 BCD110605C73 5.59 pmol/ml medium
LMFA03030002 TxB2 KDO+ATP+PLDi 1.0 BCD110605C25 5.47 pmol/ml medium
LMFA03030002 TxB2 KDO+ATP+PLDi 1.0 BCD110605C27 5.3 pmol/ml medium
LMFA03030002 TxB2 KDO+ATP+PLDi 1.0 BCD110605C26 5.34 pmol/ml medium
LMFA03030002 TxB2 KDO+ATP+PLDi 20.0 BCD110605C61 7.48 pmol/ml medium
LMFA03030002 TxB2 KDO+ATP+PLDi 20.0 BCD110605C62 7.5 pmol/ml medium
LMFA03030002 TxB2 KDO+ATP+PLDi 20.0 BCD110605C63 7.66 pmol/ml medium
LMFA03030002 TxB2 KDO + ATP 1.0 BCD110605C15 4.99 pmol/ml medium
LMFA03030002 TxB2 KDO + ATP 1.0 BCD110605C14 5.53 pmol/ml medium
LMFA03030002 TxB2 KDO + ATP 1.0 BCD110605C13 5.03 pmol/ml medium
LMFA03030002 TxB2 KDO + ATP 20.0 BCD110605C49 7.52 pmol/ml medium
LMFA03030002 TxB2 KDO + ATP 20.0 BCD110605C50 7.45 pmol/ml medium
LMFA03030002 TxB2 KDO + ATP 20.0 BCD110605C51 7.27 pmol/ml medium
LMFA03030002 TxB2 KDO 1.0 BCD110605C08 5.37 pmol/ml medium
LMFA03030002 TxB2 KDO 1.0 BCD110605C07 5.24 pmol/ml medium
LMFA03030002 TxB2 KDO 1.0 BCD110605C09 5.23 pmol/ml medium
LMFA03030002 TxB2 KDO 20.0 BCD110605C45 5.69 pmol/ml medium
LMFA03030002 TxB2 KDO 20.0 BCD110605C44 5.81 pmol/ml medium
LMFA03030002 TxB2 KDO 20.0 BCD110605C43 5.45 pmol/ml medium
LMFA03030002 TxB2 C 0.0 BCD110605C03 6.18 pmol/ml medium
LMFA03030002 TxB2 C 0.0 BCD110605C01 5.72 pmol/ml medium